{"id":82172,"date":"2021-09-02T12:39:47","date_gmt":"2021-09-02T16:39:47","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=82172"},"modified":"2021-09-02T12:39:47","modified_gmt":"2021-09-02T16:39:47","slug":"really-pfizer-producing-2x-day-pill-to-be-taken-alondside-covid-injections","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=82172","title":{"rendered":"REALLY?!?! Pfizer Producing 2X\/day Pill to be Taken Alondside Covid Injections"},"content":{"rendered":"

Pfizer Is Now Developing A Twice-Per-Day COVID Pill That Must Be Taken Alongside Vaccines<\/strong><\/h1>\n

NWO Report<\/p>\n

Pfizer is so confident the pill will be approved and likely mandated that it has started production before the end of clinical trials<\/p>\n

\n
\"\"<\/a><\/figure>\n<\/div>\n

Source:<\/strong>\u00a0Gabriel Keane | National File<\/a><\/p>\n

Pharmaceutical megacorporation pfizer is now developing a COVID pill that is meant to be taken alongside the COVID vaccines that have already made the company a staggering amount of money. The new pill is expected to be released by the end of the year and will be required to be taken twice per day.<\/h4>\n

\u201cSuccess against #COVID19 will likely require both vaccines & treatments,\u201d Pfizer CEO Albert Bourla said on Wednesday. \u201cWe\u2019re pleased to share we\u2019ve started a Phase 2\/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.\u201d<\/p>\n

\"\"<\/a><\/figure>\n

Pfizer also put out a\u00a0press release<\/a>\u00a0the same week that proclaimed, \u201cIf successful, [the drug] has the potential to address a significant unmet medical need, providing patients with a novel oral therapy that could be prescribed at the first sign of infection, without requiring hospitalization.\u201d The company described the drug as\u00a0an \u201cinvestigational orally administered protease inhibitor antiviral therapy designed specifically\u00a0to combat\u00a0COVID\u201319\u00a0\u2013\u00a0in non\u2013hospitalized, symptomatic adult participants who have a confirmed diagnosis of SARS\u2013CoV\u20132 infection and\u00a0are\u00a0not\u00a0at\u00a0increased\u00a0risk of progressing to severe illness, which may lead to\u00a0hospitalization or death.\u201d<\/p>\n

Media corporations have already expressed excitement about the new pill, and Pfizer is so confident that the pill will be swiftly approved and mandated by governments that it has already started a production line before the end of clinical trials.<\/p>\n

\n
\n
\n